TGTX - TG Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts5266
Avg. Estimate-0.44-0.37-1.99-1.56
Low Estimate-0.49-0.43-2.1-2.06
High Estimate-0.41-0.3-1.76-0.96
Year Ago EPS-0.46-0.59-1.91-1.99
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts5155
Avg. Estimate30k40k120k120k
Low EstimateN/A40kN/AN/A
High Estimate40k40k150k160k
Year Ago Sales38k38k152k120k
Sales Growth (year/est)-21.10%5.30%-21.10%0.00%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.-0.44-0.44-0.53-0.54
EPS Actual-0.46-0.59-0.59-0.43
Difference-0.02-0.15-0.060.11
Surprise %-4.50%-34.10%-11.30%20.40%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate-0.44-0.37-1.99-1.56
7 Days Ago-0.44-0.37-2.03-1.6
30 Days Ago-0.44-0.37-2.03-1.6
60 Days Ago-0.52-0.46-2.09-1.53
90 Days Ago-0.53-0.48-2.15-2.12
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesTGTXIndustrySectorS&P 500
Current Qtr.4.30%N/AN/A0.13
Next Qtr.37.30%N/AN/A0.04
Current Year-4.20%N/AN/A0.20
Next Year21.60%N/AN/A0.07
Next 5 Years (per annum)N/AN/AN/A0.13
Past 5 Years (per annum)N/AN/AN/AN/A